These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2007-004102-27||A Randomized, Double Blind, Placebo Controlled, Phase II Study Evaluating the Efficacy and Safety of RP101 in Combination with Gemcitabine Administered as First-Line Treatment to Subjects with Unresec...||2009-10-02||bad-data|
|Completed, but no date, and reported results Terminated||2015-005605-36||Thymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) chemotherapy plus cisplatin (or carboplatin) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR wild type ...||bad-data|
|Ongoing||2019-001441-40||A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients. Studio di Fase II per determinare l’attività e la tollerabilità di Timosina alfa 1 in pazi...||not-yet-due|